773
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Survivorship

High-intensity interval training and thromboembolic events during chemotherapy for testicular cancer: a retrospective analysis from the Body & Cancer cohort

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 666-672 | Received 17 Oct 2022, Accepted 07 Jun 2023, Published online: 14 Jul 2023

References

  • Smith ZL, Werntz RP, Eggener SE. Testicular cancer: epidemiology, diagnosis, and management. Med Clin North Am. 2018;102(2):251–264. doi: 10.1016/j.mcna.2017.10.003.
  • Znaor A, Skakkebaek NE, Rajpert-De Meyts E, et al. Global patterns in testicular cancer incidence and mortality in 2020. Int J Cancer. 2022;151(5):692–698.
  • Sprauten M, Haugnes HS, Brydoy M, et al. Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors. Ann Oncol. 2015;26(10):2133–2140. doi: 10.1093/annonc/mdv328.
  • Fossa SD, de Wit R, Roberts JT, et al. Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the european organization for research and treatment of cancer genitourinary group/medical research council testicular cancer study group (30941/TE20). J Clin Oncol. 2003;21(6):1107–1118. doi: 10.1200/JCO.2003.02.075.
  • Chovanec M, Lauritsen J, Bandak M, et al. Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nat Rev Urol. 2021;18(4):227–245. doi: 10.1038/s41585-021-00440-w.
  • Christensen JF, Bandak M, Campbell A, et al. Treatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship. Acta Oncol. 2015;54(5):592–599. doi: 10.3109/0284186X.2014.995776.
  • Lauritsen J, Hansen MK, Bandak M, et al. Cardiovascular risk factors and disease after male germ cell cancer. J Clin Oncol. 2020;38(6):584–592. doi: 10.1200/JCO.19.01180.
  • Fung C, Fossa SD, Milano MT, et al. Cardiovascular disease mortality after chemotherapy or surgery for testicular nonseminoma: a Population-Based study. J Clin Oncol. 2015;33(28):3105–3115. doi: 10.1200/JCO.2014.60.3654.
  • Amiri A, Chovanec M, Oliva V, et al. Chemotherapy-induced toxicity in patients with testicular germ cell tumors: the impact of physical fitness and regular exercise. Andrology. 2021;9(6):1879–1892. doi: 10.1111/andr.13078.
  • Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375–2390. doi: 10.1249/MSS.0000000000002116.
  • Christensen JF, Jones LW, Tolver A, et al. Safety and efficacy of resistance training in germ cell cancer patients undergoing chemotherapy: a randomized controlled trial. Br J Cancer. 2014;111(1):8–16. doi: 10.1038/bjc.2014.273.
  • Thorsen L, Kirkegaard C, Loge JH, et al. Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer. BMC Res Notes. 2017;10(1):214. doi: 10.1186/s13104-017-2531-y.
  • Adams SC, DeLorey DS, Davenport MH, et al. Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: a phase 2 randomized controlled trial. Cancer. 2017;123(20):4057–4065. doi: 10.1002/cncr.30859.
  • Adams SC, DeLorey DS, Davenport MH, et al. Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors. Br J Cancer. 2018;118(10):1313–1321. doi: 10.1038/s41416-018-0044-7.
  • Thorsen L, Haugnes HS, Fossa SD, et al. Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: case reports and review of the literature. Int J Cancer. 2020;147(11):3189–3198. doi: 10.1002/ijc.33151.
  • Adamsen L, Quist M, Andersen C, et al. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ. 2009;339:b3410. doi: 10.1136/bmj.b3410.
  • Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019; 13(Suppl 1):S31–S34. doi: 10.4103/sja.SJA_543_18.
  • Levinger I, Goodman C, Hare DL, et al. The reliability of the 1RM strength test for untrained middle-aged individuals. J Sci Med Sport. 2009;12(2):310–316. doi: 10.1016/j.jsams.2007.10.007.
  • Andersen LB. A maximal cycle exercise protocol to predict maximal oxygen uptake. Scand J Med Sci Sports. 1995; 5(3):143–146. doi: 10.1111/j.1600-0838.1995.tb00027.x.
  • Quist M, Rorth M, Zacho M, et al. High-intensity resistance and cardiovascular training improve physical capacity in cancer patients undergoing chemotherapy. Scand J Med Sci Sports. 2006;16(5):349–357. doi: 10.1111/j.1600-0838.2005.00503.x.
  • Grimby G, Borjesson M, Jonsdottir IH, et al. The ‘Saltin-Grimby physical activity level scale’ and its application to health research. Scand J Med Sci Sports. 2015;25 Suppl 4(Suppl 4):119–125. doi: 10.1111/sms.12611.
  • International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. International germ cell cancer collaborative group. J Clin Oncol. 1997; 15(2):594–603.
  • Horwich A, Dearnaley DP, Duchesne GM, et al. Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. J Clin Oncol. 1989;7(8):1150–1156. doi: 10.1200/JCO.1989.7.8.1150.
  • Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902–4907. doi: 10.1182/blood-2007-10-116327.
  • Dieckmann KP, Marghawal D, Pichlmeier U, et al. Thromboembolic events in patients with testicular germ cell tumours are predominantly triggered by advanced disease and by central venous access systems. Urol Int. 2021;105(3-4):257–263. doi: 10.1159/000512055.
  • Bezan A, Posch F, Ploner F, et al. Risk stratification for venous thromboembolism in patients with testicular germ cell tumors. PLoS One. 2017;12(4):e0176283. doi: 10.1371/journal.pone.0176283.
  • Astrand I. Aerobic work capacity in men and women with special reference to age. Acta Physiol Scand Suppl. 1960;49(169):1–92.
  • Cheng W, Zhang Z, Cheng W, et al. Associations of leisure-time physical activity with cardiovascular mortality: a systematic review and meta-analysis of 44 prospective cohort studies. Eur J Prev Cardiol. 2018;25(17):1864–1872. doi: 10.1177/2047487318795194.
  • Kunutsor SK, Makikallio TH, Seidu S, et al. Physical activity and risk of venous thromboembolism: systematic review and meta-analysis of prospective cohort studies. Eur J Epidemiol. 2020;35(5):431–442. doi: 10.1007/s10654-019-00579-2.
  • Franklin BA, Thompson PD, Al-Zaiti SS, et al. Exercise-related acute cardiovascular events and potential deleterious adaptations following long-term exercise training: placing the risks into perspective-an update: a scientific statement from the American heart association. Circulation. 2020;141(13):e705–e736. doi: 10.1161/CIR.0000000000000749.
  • Tuzovic M, Herrmann J, Iliescu C, et al. Arterial thrombosis in patients with cancer. Curr Treat Options Cardiovasc Med. 2018;20(5):40.
  • Abdol Razak NB, Jones G, Bhandari M, et al. Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment. Cancers. 2018;10(10):380. doi: 10.3390/cancers10100380.
  • Dieckmann KP, Struss WJ, Budde U. Evidence for acute vascular toxicity of cisplatin-based chemotherapy in patients with germ cell tumour. Anticancer Res. 2011; 31(12):4501–4505.
  • Moore RA, Adel N, Riedel E, et al. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. J Clin Oncol. 2011;29(25):3466–3473. doi: 10.1200/JCO.2011.35.5669.
  • Haugnes HS, Negaard HF, Jensvoll H, et al. Thromboembolic events during treatment with cisplatin-based chemotherapy in metastatic testicular germ-cell cancer 2000–2014: a population-based cohort study. Eur Urol Open Sci. 2021;32:19–27. doi: 10.1016/j.euros.2021.07.007.
  • Olsen LN, Fischer M, Evans PA, et al. Does exercise influence the susceptibility to arterial thrombosis? An integrative perspective. Front Physiol. 2021;12:636027. doi: 10.3389/fphys.2021.636027.
  • Wewege MA, Ahn D, Yu J, et al. High-intensity interval training for patients with cardiovascular disease-Is it safe? A systematic review. J Am Heart Assoc. 2018;7(21):e009305.
  • Wallen MP, Hennessy D, Brown S, et al. High-intensity interval training improves cardiorespiratory fitness in cancer patients and survivors: a meta-analysis. Eur J Cancer Care (Engl). 2020;29(4):e13267. doi: 10.1111/ecc.13267.
  • Mugele H, Freitag N, Wilhelmi J, et al. High-intensity interval training in the therapy and aftercare of cancer patients: a systematic review with meta-analysis. J Cancer Surviv. 2019;13(2):205–223. doi: 10.1007/s11764-019-00743-3.
  • Lavin-Perez AM, Collado-Mateo D, Mayo X, et al. High-intensity exercise to improve cardiorespiratory fitness in cancer patients and survivors: a systematic review and meta-analysis. Scand J Med Sci Sports. 2021;31(2):265–294. doi: 10.1111/sms.13861.
  • Egegaard T, Rohold J, Lillelund C, et al. Pre-radiotherapy daily exercise training in non-small cell lung cancer: a feasibility study. Rep Pract Oncol Radiother. 2019;24(4):375–382. Jul-Augdoi: 10.1016/j.rpor.2019.06.003.
  • Edvardsen E, Skjonsberg OH, Holme I, et al. High-intensity training following lung cancer surgery: a randomised controlled trial. Thorax. 2015;70(3):244–250. Mardoi: 10.1136/thoraxjnl-2014-205944.
  • Quist M, Langer SW, Lillelund C, et al. Effects of an exercise intervention for patients with advanced inoperable lung cancer undergoing chemotherapy: a randomized clinical trial. Lung Cancer. 2020;145:76–82. Juldoi: 10.1016/j.lungcan.2020.05.003.